Monoamine transporter and sodium channel mechanisms in the rapid presser response to cocaine

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 2, 1998, Pages 305-312

  Tella, Srihari R ^a   Goldberg, Steven R ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Behavior; Blood pressure; Cardiovascular; Cocaine; Dopamine; Inhibition; Monoamine uptake; Sodium channel blockade

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACECAINIDE; CINCHOCAINE; COCAINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DYCLONINE; INDATRALINE; MAZINDOL; MONOAMINE; MONOAMINE TRANSPORTER; NOMIFENSINE; NORCOCAINE; PRILOCAINE; PROXYMETACAINE; QUINIDINE; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; TETRACAINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFECT; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOGENIC MONOAMINES; BLOOD PRESSURE; CARRIER PROTEINS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; NEUROTRANSMITTER UPTAKE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHANNELS; TELEMETRY;

EID: 0032004913     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00448-6     Document Type: Article

References (58)

1. Bajaj A. K., Kopelman H. A., Wikswo J. P. Jr., Cassidy F., Woosley R. L., Roden D. M. Frequency- and orientation-dependent effects of mexiletine and quinidine on conduction in the intact dog heart. Circulation. 75:1987;1065-1073.
2. Bergman J., Madras B. K., Johnson S. E., Spealman R. D. Effects of cocaine and related drugs in nonhuman primates. III Self-administration by squirrel monkeys. J. Pharmacol. Exp. Ther. 251:1989;150-155.
3. 2 receptors in maintaining cocaine self-administration. Pharmacol. Biochem. Behav. 39:1991;911-915.
4. Carroll M. E., Krattiger K. L., Gieske D., Sadoff D. A. Cocaine-base smoking in rhesus monkeys. Reinforcing and physiological effects Psychopharmacology (Berlin). 102:1990;443-450.
5. Chen B. X., Wilkerson R. D. Role of sympathetic neurons and adrenal medulla in the cardiovascular response to cocaine in conscious, unrestrained rats. FASEB J. 6:1992;A1177.
6. Chiueh C. C., Kopin I. J. Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanesthetized rats. J. Pharmacol. Exp. Ther. 205:1978;148-154.
7. 125I]RTI-55 to dopamine transporters. Pharmacology and regional distribution with autoradiography Synapse. 12:1992;37-46.
8. 2 dopamine antagonists. Pharmacol. Biochem. Behav. 39:1991;799-802.
9. De Wit H., Wise R. A. Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with noradrenergic blockers phentolamine and phenoxybenzamine. Can. J. Psychol. 31:1977;195-203.
10. Fischman M. W., Schuster C. R., Resnekov L., Shick J. F. E., Krasnegor N. A., Fennell W., Freedman D. X. Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch. Gen. Psychiatry. 33:1976;983-989.
11. Foltin R. W., Fischman M. W., Levin F. R. Cardiovascular effects of cocaine in humans. Laboratory studies Drug Alcohol Depend. 37:1995;193-210.
12. Garfield J. M., Gugino L. Central effects of local anesthetic agents. Strichartz G. R. Local anesthetics. 1987;253-284 Springer Verlag, New York.
13. Gonzalez F. A., Byrd L. D. Physiological effects of cocaine in the squirrel monkey. Life Sci. 21:1977;1417-1424.
14. Howell L. L., Byrd L. D. Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J. Pharmacol. Exp. Ther. 258:1991;178-185.
15. 2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology (Berlin). 105:1991;151-156.
16. Javaid J. I., Fischman M. W., Schuster C. R., Dekirmenjian H., David J. M. Cocaine plasma concentration. Relation to physiological and subjective effects in humans Science. 202:1978;227-228.
17. Johanson C. E., Fischman M. W. The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41:1989;3-52.
18. Just W. W., Hoyer J. The local anesthetic potency of norcocaine, a metabolite of cocaine. Experientia. 33:1977;70-71.
19. Kelly P., Iversen S. D. Selective 6OHDA-induced destruction of mesolimbic dopamine neurons. Abolition of psychostimulant-induced locomotor activities in rats Eur. J. Pharmacol. 40:1976;45-56.
20. Kennedy L. T., Hanbauer I. Sodium-sensitive cocaine binding to striatal membranes. Possible relationship to dopamine uptake sites J. Neurochem. 41:1983;172-178.
21. Kiritsy-Roy J. A., Halter J. B., Gordon S. M., Smith M. J., Terry L. C. Role of the nervous system in hemodynamic and sympathoadrenal responses to cocaine in rats. J. Pharmacol. Exp. Ther. 255:1990;154-160.
22. Knuepfer M. M., Branch C. A. Cardiovascular responses to cocaine are initially mediated by the central nervous system in rats. J. Pharmacol. Exp. Ther. 263:1992;734-741.
23. Koob G. F., Vaccarino F. J., Amalric M., Bloom F. E. Positive reinforcement properties of drugs. Search for neural substrates Engel J., Oreland L. Brain reward systems and abuse. 1987;35-50 Raven Press, New York.
24. Kumor K. M., Shere M. A., Thompson L., Cone E., Mahafey J., Jaffe J. Lack of cardiovascular tolerance during intravenous cocaine infusions in human volunteers. Life Sci. 42:1988;2063-2071.
25. 3H]cocaine binding sites in caudate-putamen. J. Pharmacol. Exp. Ther. 251:1989;131-141.
26. Mathews J. C., Collins A. Interactions of cocaine and cocaine congeners with sodium channels. Biochem. Pharmacol. 32:1983;455-460.
27. Matsuzaki M., Spingler P. J., Whitlock E. G., Misra A. L., Mule S. J. Comparative effects of cocaine and pseudococaine on EEG activities, cardiorespiratory functions, and self-administration behavior in the rhesus monkey. Psychopharmacology (Berlin). 57:1978;13-20.
28. Morady F., Dicarlo L. A., Baerman J. M., Krol R. B. Rate-dependent effects of intravenous lidocaine, procainamide and amiodorone on intraventricular conduction. J. Am. Coll. Cardiol. 6:1985;179-185.
29. Muscholl E. Effects of cocaine and related drugs on the uptake of noradrenaline by heart and spleen. Br. J. Pharmacol. 16:1961;352-359.
30. Pagel P. S., Tessmer J. P., Warltier D. C. Systemic and coronary hemodynamic effects of repetitive cocaine administration in conscious dogs. J. Cardiovas. Pharmacol. 24:1994;443-453.
31. Ranger S., Talajic M., Lemery R., Roy D., Villemaire C., Nattel S. Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans. Circulation. 83:1991;1987-1994.
32. 3H]batrachotoxin A 20-a-benzoate binding sites on sodium channels in mouse brain synaptosomes. J. Biol. Chem. 261:1986;7300-7305.
33. Resnick R. B., Kestenbaum R. S., Schwartz L. K. Acute systemic effects of cocaine in man. A controlled study by intranasal and intravenous routes Science. 195:1977;696-698.
34. Ritz M. C., Lamb R. J., Goldberg S. R., Kuhar M. J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
35. Roberts D. C. S. Neural substrates mediating cocaine reinforcement. The role of monoamine systems Lakoski J. M., Galloway M. P., White F. J. Cocaine. Pharmacology, physiology and clinical strategies:1992;73-90 CRC Press, Boca Raton, FL. FL;
36. 125I]RTI-55, an in vivo label for the serotonin transporter. Synapse. 11:1992;134-139.
37. 3H]WIN 35,428. J. Pharmacol. Exp. Ther. 257:1991;954-958.
38. Schindler C. W., Tella S. R., Witkin J. M., Goldberg S. R. Effects of cocaine alone and in combination with haloperidol and SCH 23390 on cardiovascular function in squirrel monkeys. Life Sci. 48:1991;1547-1554.
39. Schindler C. W., Tella S. R., Katz J. L., Goldberg S. R. Effects of cocaine and its quaternary derivative cocaine methiodide on cardiovascular function in squirrel monkeys. Eur. J. Pharmacol. 213:1992;99-105.
40. 3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinson disease. Naunyn Schmiedebergs Arch. Pharmacol. 329:1985;227-235.
41. Smith T. L., Callahan M., Williams D., Dworkin S. I. Tachyphylaxis in cardiovascular responses to cocaine in conscious rats. J. Cardiovasc. Pharmacol. 21:1993;272-278.
42. Spealman R. D. Antagonism of behavioral effects of cocaine by selective dopamine receptor blockers. Psychopharmacology (Berlin). 101:1990;142-145.
43. Spealman R. D., Bergman J., Madras B. K., Melia K. F. Discriminative stimulus effects of dopamine receptor subtypes. J. Pharmacol. Exp. Ther. 258:1991;945-953.
44. Spealman R. D., Kelleher R. T., Goldberg S. R. Stereoselective behavioral effects of cocaine and a phenyltropane analog. J. Pharmacol. Exp. Ther. 225:1983;509-514.
45. Spealman R. D., Madras B. K., Bergman J. Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior. J. Pharmacol. Exp. Ther. 251:1989;142-149.
46. Stambler B. S., Komamura K., Ihara T., Shannon R. P. Acute intravenous cocaine causes transient depression followed by enhanced left ventricular function in conscious dogs. Circulation. 87:1993;1687-1697.
47. Szabo B., Obergfell A., Starke K. Involvement of monoamine uptake inhibition and local anesthesia in the cardiovascular re-sponse to cocaine in conscious rabbits. J. Pharmacol. Exp. Ther. 273:1995;128-137.
48. Tella S. R. Differential blockade of chronic vs. acute effects of intravenous cocaine by dopamine receptor antagonists. Pharmacol. Biochem. Behav. 48:1994;151-159.
49. Tella S. R. Possible novel pharmacodynamic action of cocaine. Cardiovascular and behavioral evidence Pharmacol. Biochem. Behav. 54:1996;343-354.
50. Tella S. R., Schindler C. W., Goldberg S. R. The role of central and autonomic neural mechanisms in the cardiovascular effects of cocaine in conscious squirrel monkeys. J. Pharmacol. Exp. Ther. 252:1990;491-499.
51. Tella S. R., Schindler C. W., Goldberg S. R. Cardiovascular effects of cocaine in conscious rats. Relative significance of central sympathetic stimulation and peripheral neuronal monoamine uptake and release mechanisms J. Pharmacol. Exp. Ther. 262:1992;602-610.
52. Tella S. R., Schindler C. W., Goldberg S. R. Cocaine. Cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system J. Pharmacol. Exp. Ther. 267:1993;153-162.
53. Tella S. R., Schindler C. W., Goldberg S. R. Chlorisondamine, a noncompetitive ganglionic blocker, antagonizes the cardiovascular effects of cocaine in conscious squirrel monkeys. Pharmacol. Res. 27:1993;233-239.
54. Weiss S. R. B., Post R. M., Pert A., Woodward R., Murman D. Context-dependent cocaine sensitization. Differential effect of haloperidol on development vs expression. Pharmacol. Biochem. Behav. 34:1989;655-661.
55. Wilkerson R. D. Cardiovascular effects of cocaine in conscious dogs. Importance of fully functional autonomic and central nervous systems J. Pharmacol. Exp. Ther. 246:1988;466-471.
56. Wilkinson L. SYSTAT. The system for statistics:1989;SYSTAT, Inc, Evanston, IL.
57. Woolverton W. L., Kleven M. S. Multiple dopamine receptors and the behavioral effects of cocaine. Natl. Inst. Drug Abuse Res. Monogr. 88:1988;160-184.
58. Xu Y.-Q., Crumb W. J. Jr., Clarkson C. W. A metabolite of cocaine and ethanol, is a potent blocker of cardiac sodium channels. J. Pharmacol. Exp. Ther. 271:1994;319-325.